Skip to main content

Advertisement

Table 1 Osteoporotic fracture outcomes according to treatment group

From: The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial

Osteoporotic fractures B-Vitamins Placebo Relative risk p-value
(n = 4089) (n = 4075) (95% confidence interval) (log-rank test)
N (%) N (%)   
Any 67 (1.6) 78 (1.1) 0.86 (0.62,1.18) 0.32
Hip 34 (0.8) 36 (0.9) 0.94 (0.59,1.50) 0.77
Wrist 7 (0.2) 8 (0.1) 0.87 (0.32,2.40) 0.78
Thoracic spine 4 (0.1) 5 (0.1) 0.80 (0.21,2.97) 0.70
Other 26 (0.6) 35 (0.9) 0.74 (0.45,1.23) 0.24
  1. Note: Only first fracture was used for each type of events. One patient could have multiple different types of fractures, so sum of fracture types could be more than the total of fractures.